Press Releases Choose Year All Items 2026 2025 2024 Search Press Releases Found 39 Results September 3, 2026 LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer September 3, 2026 LB Pharmaceuticals to Participate in Upcoming September Investor Events August 11, 2026 LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update July 29, 2026 LB Pharmaceuticals Announces $150 Million Private Placement July 22, 2026 LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia July 10, 2026 LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) June 30, 2026 LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations May 28, 2026 LB Pharmaceuticals to Participate in Upcoming June Investor Events May 12, 2026 LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update April 22, 2026 LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia 1234»
